Mature T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Mature T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: EZH2 Inhibitor Zeprumetostat in Combination Therapy for Patients With Relapsed or Refractory Mature T-cell and NK-cell Lymphomas [Phase 1, Phase 2]
Zeprumetostat, an EZH2 inhibitor, is being evaluated in combination therapy for relapsed or refractory mature T-cell and NK-cell lymphomas. …